BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29100503)

  • 1. Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.
    Winther JA; Brynildsen J; Høiseth AD; Strand H; Følling I; Christensen G; Nygård S; Røsjø H; Omland T
    Respir Res; 2017 Nov; 18(1):184. PubMed ID: 29100503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and diagnostic significance of mid-regional pro-atrial natriuretic peptide in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 Study.
    Pervez MO; Winther JA; Brynildsen J; Strand H; Christensen G; Høiseth AD; Myhre PL; Røysland R; Lyngbakken MN; Omland T; Røsjø H
    Biomarkers; 2018 Nov; 23(7):654-663. PubMed ID: 29733687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commenting on "Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from ACE 2 study" by Jacob A. Winther and colleagues.
    Castello LM; Bellan M
    Respir Res; 2018 Mar; 19(1):35. PubMed ID: 29490639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimized combination of circulating biomarkers as predictors of prognosis in AECOPD patients complicated with Heart Failure.
    Yao C; Wang L; Shi F; Chen R; Li B; Liu W; Feng M; Li S
    Int J Med Sci; 2021; 18(7):1592-1599. PubMed ID: 33746575
    [No Abstract]   [Full Text] [Related]  

  • 5. Mid-regional pro-adrenomedullin in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
    Pervez MO; Lyngbakken MN; Myhre PL; Brynildsen J; Langsjøen EC; Høiseth AD; Christensen G; Omland T; Røsjø H
    Clin Biochem; 2017 May; 50(7-8):394-400. PubMed ID: 28065681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD.
    Li H; Zeng Z; Cheng J; Hu G; Li Y; Wei L; Zhou Y; Ran P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():57-67. PubMed ID: 32021144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copeptin and risk stratification in patients with acute dyspnea.
    Potocki M; Breidthardt T; Mueller A; Reichlin T; Socrates T; Arenja N; Reiter M; Morgenthaler NG; Bergmann A; Noveanu M; Buser PT; Mueller C
    Crit Care; 2010; 14(6):R213. PubMed ID: 21106053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study.
    Wannamethee SG; Welsh P; Whincup PH; Lennon L; Papacosta O; Sattar N
    Eur J Heart Fail; 2014 Jan; 16(1):25-32. PubMed ID: 23901058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
    Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
    Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD - a prospective cohort study.
    Høiseth AD; Omland T; Hagve TA; Brekke PH; Søyseth V
    Respir Res; 2012 Oct; 13(1):97. PubMed ID: 23107284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Terminal Prohormone of Brain Natriuretic Peptide (NT-proBNP) as a Diagnostic Biomarker of Left Ventricular Systolic Dysfunction in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD).
    Andrijevic I; Milutinov S; Lozanov Crvenkovic Z; Matijasevic J; Andrijevic A; Kovacevic T; Bokan D; Zaric B
    Lung; 2018 Oct; 196(5):583-590. PubMed ID: 29951921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
    Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
    Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic performance of copeptin among patients with acute decompensated heart failure.
    Ozmen C; Deveci OS; Tepe O; Yesildas C; Ünal İ; Yıldız İ; Eker Akıllı R; Deniz A; Demir M; Kanadaşı M; Usal A
    Acta Cardiol; 2021 Oct; 76(8):842-851. PubMed ID: 32666903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study.
    Winther JA; Brynildsen J; Høiseth AD; Følling I; Brekke PH; Christensen G; Hagve TA; Verbalis JG; Omland T; Røsjø H
    PLoS One; 2016; 11(8):e0161232. PubMed ID: 27529844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized evaluation of lung congestion during COPD exacerbation better identifies patients at risk of dying.
    Høiseth AD; Omland T; Karlsson BD; Brekke PH; Søyseth V
    Int J Chron Obstruct Pulmon Dis; 2013; 8():621-9. PubMed ID: 24353412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 in patients with acute dyspnea: Data from the Akershus Cardiac Examination (ACE) 2 Study.
    Lyngbakken MN; Pervez MO; Brynildsen J; Pedersen MH; Sølvernes J; Christensen G; Høiseth AD; Omland T; Røsjø H
    Clin Biochem; 2018 Feb; 52():41-47. PubMed ID: 29074091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting.
    Prosen G; Klemen P; Štrnad M; Grmec S
    Crit Care; 2011; 15(2):R114. PubMed ID: 21492424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.
    Balling L; Kistorp C; Schou M; Egstrup M; Gustafsson I; Goetze JP; Hildebrandt P; Gustafsson F
    J Card Fail; 2012 May; 18(5):351-8. PubMed ID: 22555263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.